Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Co-diagnostics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.136 Good day, everyone, and thank you all for joining today's CoDiagnostics, Inc. 00:00:04.136 -- 00:00:09.242 Full Year 2025 Earnings Webcast. As a reminder, all phone participants 00:00:09.242 -- 00:00:13.307 are in a listen-only mode, but later you will be provided with the opportunity to ask 00:00:13.307 -- 00:00:15.470 a question during our question and answer session. 00:00:15.470 -- 00:00:18.854 As a reminder, today's session is being recorded. 00:00:18.854 -- 00:00:24.061 And it is now my pleasure to turn the floor over to Head of Investor Relations, Mr. 00:00:24.061 -- 00:00:27.663 Andrew Benson. Please go ahead, sir. 00:00:27.757 -- 00:00:31.943 Good afternoon, everyone. Thank you all for participating in today's conference call. 00:00:31.943 -- 00:00:36.290 On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and 00:00:36.290 -- 00:00:41.457 Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial 00:00:41.457 -- 00:00:46.562 results from the fourth quarter and full year ended December 31, 2025. 00:00:46.885 -- 00:00:50.090 A copy of the press release is available on the company's website. 00:00:50.090 -- 00:00:54.216 We will begin with management's prepared remarks and then open up the call to analyst 00:00:54.216 -- 00:00:58.552 Q&A. Before we begin, we would like to inform listeners that certain statements made 00:00:58.552 -- 00:01:02.637 by co-diagnostics during this call, which are not historical facts, are forward-looking 00:01:02.637 -- 00:01:06.702 statements. In addition to diagnostic test developments and timing for commencement of 00:01:06.702 -- 00:01:11.788 clinical evaluations, this includes statements concerning the company's CODIX PCR 00:01:11.788 -...